Okay. I'm going to switch it over.
Canadians in my riding who suffer from cystic fibrosis are among the most vulnerable to COVID-19 infection. While these Canadians with existing lung conditions are incredibly worried about a virus that attacks the ability to breathe, the good news is that there are life-saving medicines for those with CF. The problem is with the Patented Medicine Prices Review Board and its restrictive guidelines.
I am wondering if and when the government will correct these guidelines and give access to life-saving medicines for our most vulnerable.